ReviewRenal failure2025
A rare case of sero-negative anti-glomerular basement membrane disease combined with diabetic nephropathy and literature review.
Review in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A multi-organ atlas of microcirculatory signatures for systemic profiling of diabetic and therapeutic states.Scientific data · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a 59-year-old male who exhibited an insidious onset of hematuria, nephrotic syndrome, and mild renal dysfunction, with negative serum anti-glomerular basement membrane antibodies. The initial renal biopsy diagnosed diabetic nephropathy. As the disease progressed, the clinical manifestations evolved into rapidly progressive glomerulonephritis, and a second kidney biopsy ultimately diagnosed anti-glomerular basement membrane disease in conjunction with diabetic nephropathy. Furthermore, we incubated normal renal tissue with both the patient's serum and serum from an anti-GBM antibody-positive patient, and observed identical linear IgG deposition along the basement membrane. This result indirectly suggests the presence of anti-GBM antibodies in the patient's serum. Despite receiving immunosuppressive treatment, renal function did not improve, and the patient ultimately required maintenance renal replacement therapy. This case highlights the importance of closely monitoring disease progression in atypical presentations of rare diseases and emphasizes the necessity of repeat renal biopsies for the accurate diagnosis of sero-negative anti-glomerular basement membrane disease. We diagnosed the anti-GBM disease using an indirect immunofluorescence antibody method and we need more detection methods to determine the target antigen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.